Log In
BCIQ
Print this Print this
 

SMRX11

  Manage Alerts
Collapse Summary General Information
Company Nostrum Pharmaceuticals LLC
DescriptionRecombinant plasminogen activating hybrid protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationThrombosis
Indication DetailsTreat thrombosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today